Eli Lilly (LLY) Stock Up Almost 50% Year to Date: Here's Why
August 17, 2023 at 15:09 PM EDT
Eli Lilly and Company (LLY) boasts a solid portfolio of core drugs in diabetes, autoimmune diseases and cancer.
|
||||||||||||
![]() |
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
San Anselmo | San Anselmo News | San Anselmo Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|